Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules.
Journal: Clinical genitourinary cancer
Published: February 11, 2026
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.
Journal: JCO oncology practice
Published: June 16, 2025
Advancing Perioperative Treatment Options for Localized Muscle-Invasive Bladder Cancer: A Step Forward.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 20, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
Journal: ESMO open
Published: April 03, 2025
Enfortumab vedotin and pembrolizumab: redefining the standard of care for previously untreated advanced urothelial cancer.
Journal: Future oncology (London, England)
Published: March 25, 2025
Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer.
Journal: World journal of gastrointestinal oncology
Published: May 23, 2023
Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.
Journal: The Lancet. Oncology
Published: October 05, 2022
ANTIBODY-DRUG CONJUGATES - A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC UROTHELIAL CARCINOMA
Journal: Harefuah
Published: January 25, 2022
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
Journal: Oncology
Published: March 12, 2021
Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis.
Journal: Journal of cancer research and clinical oncology
Published: December 29, 2020
Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta-analysis.
Journal: Cancer medicine
Published: May 13, 2020
Last Updated: 09/26/2026